Pfizer Inc. (NYSE: PFE) will close its research and development (R&D) facility in Sandwich, Kent, England, which presently employs 2,400 people, the “majority” of which would be made redundant over the next two years.
Pfizer Inc
cut its sales forecast for 2012, the first full year its $10 billion-a-year Lipitor cholesterol fighter faces cheaper U.S. generics, but slashed its research budget to keep its profit view intact that year.The companies which are expected to see active trade on Tuesday are: BP, Pfizer, C.H. Robinson, Emerson, United Parcel, McGraw Hill Companies, Lexmark International and Cummins.
Earnings reports and acquisition announcements took a back seat to the violent unrest in Egypt today, as U.S. stocks fall.
U.S. generic drug maker Mylan Inc has settled two U.S. patent disputes with global pharma giant Pfizer Inc, which will enable the former to sell the generic versions of cholesterol drug Lipitor and combination blood pressure and cholesterol treatment Caduet.
Europe's drive to cut drug prices as well as U.S. healthcare reforms are likely to dampen global pharmaceutical companies' growth outlooks for 2011.
Indian pharmaceutical company Dr Reddy's Laboratories Ltd on Thursday said it has launched a generic version of Protonix, a drug used to control the amount of acid in the stomach, in the United States.
While Chinese President Hu Jintao is being entertained by U.S. President Barack Obama, and the U.S. House of Representatives votes to repeal the Obama administration’s healthcare reform law, both U.S. healthcare and Sino-American relations are the main components today of a less highly publicized event.
Scientists have found a protein that acts as a master switch to determine whether certain white blood cells will boost or dampen inflammation, a finding that may help the search for new drugs for rheumatoid arthritis.
A federal court in Alabama will centralize at least 1,200 civil lawsuits against Pfizer Inc over its smoking-cessation drug Chantix, which plaintiffs say can lead to suicide.
World’s largest drug maker Pfizer has moved the court against Dr Reddy’s Laboratories seeking a delay in launching the Indian drug maker’s low-cost version of atorvastatin, the world’s best-selling medicine, in the US market.
Pfizer (NYSEL PFE) has recalled about 19,000 bottles of its Lipitor tablets after an “uncharacteristic odor” was reported in a bottle of the blockbuster cholesterol drug
Swiss drug maker Novartis will pay $12.9 billion to buy the remaining shares of Alcon it doesn't already own to broaden its presence in the booming eye-care market, which is expected to outgrow the pharmaceuticals market in coming years.
Pfizer Inc
named board member George Lorch as nonexecutive chairman, a week after the abrupt departure of Chairman and Chief Executive Jeffrey Kindler from the world's largest drugmaker.Pfizer Inc
said on Monday that board member George Lorch was elected nonexecutive chairman of the board, effective immediately, and the world's largest drugmaker raised its dividend by about 11 percent.U.S. drug giant Pfizer (NYSE: PFE) hired investigators to dig up dirt on Nigeria’s former attorney general in order to stop an investigation over a controversial drug trial the company conducted which led to the deaths of eleven children, according to cables released by WikiLeaks.
Drugmaker Pfizer hired investigators to find evidence of corruption against the Nigerian attorney general to convince him to drop legal action against the company over a drug trial involving children, the Guardian newspaper reported, citing U.S. diplomatic cables made public by WikiLeaks.
Wall Street initially welcomed the abrupt departure of Pfizer Inc CEO Jeffrey Kindler, but quickly turned to questions about the condition of the pharmaceutical company and the behavior of its board.
S&P 500 Index slid 3.63 points, or 0.31 percent, to trade at 1,220.95 at 09:55 a.m. EST. The Dow Jones Industrial Average is down 30.08 points, or 0.26 percent, to trade at 11,352.01. The Nasdaq Composite Index fell 0.28 percent to trade at 2,584.64.
Kellogg Co. (NYSE: K) said chief executive David Mackay announced his plans to step down, and he will be succeeded by chief operating officer John Bryant, effective January 2, 2011. The cereal giant also reaffirmed its 2010 and 2011 sales and profit forecasts.
Investors welcomed the sudden departure of Pfizer Inc CEO Jeffrey Kindler by pushing up the stock in the hopes that a new leader will more act more aggressively to revive the giant pharmaceutical company.
Futures on the S&P 500 are down 0.30 percent to 1,219.80, futures on the Dow Jones Industrial Average are down 0.21 percent to 11,340.00 and Nasdaq100 futures are down 0.19 percent to 2,183.00.
